Welcome to LookChem.com Sign In|Join Free
  • or
Cyclobutanecarboxamide, N,N-dimethyl-3-oxo- (6CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

98431-64-2

Post Buying Request

98431-64-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

98431-64-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 98431-64-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,4,3 and 1 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 98431-64:
(7*9)+(6*8)+(5*4)+(4*3)+(3*1)+(2*6)+(1*4)=162
162 % 10 = 2
So 98431-64-2 is a valid CAS Registry Number.

98431-64-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N,N-dimethyl-3-oxocyclobutanecarboxamide

1.2 Other means of identification

Product number -
Other names 3-oxo-cyclobutanecarboxylic acid dimethylamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:98431-64-2 SDS

98431-64-2Relevant academic research and scientific papers

TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF

-

, (2017/01/23)

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.

IRAK INHIBITORS AND USES THEREOF

-

Page/Page column 166-167, (2012/07/28)

The present invention relates to compounds and methods useful for inhibiting one or more interleukin-l receptor-associated kinases ("IRAK"). In some embodiments, a provided compound inhibits IRAK-1 and IRAK-4. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 98431-64-2